Location & dates Virtual 25 - 27 May 2021 Register Now
Deadlines Registration - 3 May 2021 Abstract - 22 Mar 2021

EMBL Courses and Conferences during the Coronavirus pandemic

With the onsite programme paused, many of our events are now being offered in virtual formats.

Registration is open as usual for many events, with back-up plans in place to move further courses and conferences online as necessary. Registration fees for any events affected by the COVID-19 disruption are fully refundable.

More information for participants of events at EMBL Heidelberg can be found here.

EMBL is committed to sharing research advances and sustaining scientific interaction throughout the coronavirus pandemic. We are delighted to announce that the conference is going virtual and invite you to join us online. The virtual conference includes talks from invited speakers, short talk presenters, online group discussions and networking opportunities.

Conference Overview

Malaria remains one of the most significant global public health challenges, with more than 200 million clinical cases worldwide each year. The lack of an effective licensed vaccine and the continual emergence of drug-resistant malaria parasites emphasizes the need for new control and prevention strategies. This need for innovation has become even more apparent with the disruption of global malaria control programs due to the COVID-19 pandemic and potential reversal of gains made over the last few decades. Generation of fundamental knowledge lies at the heart of developing new tools and innovations for malaria intervention. The malaria research community has a long history of being a highly collaborative field, reliant on diverse technologies, sharing of resources and dissemination of biological advances made. Accessibility and timely sharing of these advances through the establishment of new collaborations is therefore vital for the translation of new ideas into public health impact. 

The 17th BioMalPar conference follows the success of previous years, building on the foundations of the EU-funded Networks of Excellence EviMalaR and BioMalPar that, for one and a half decades, have brought together malaria researchers from around the world to present and share recent ground-breaking findings on fundamental malaria research in an integrated and highly collaborative environment. This year’s conference will address fundamental questions on the biology of the malaria parasite, its vector, the immune response of the host, the disease that it causes, and the latest technological approaches. In keeping with the traditions of BioMalPar and EviMalaR, the conference will emphasise training and networking, with a focus on allowing speaking opportunities for early career researchers. 

Session Topics

  • Host-parasite interactions
  • Parasite biology
  • Immunology and vaccinology
  • Epidemiology and clinical malaria
  • Drug resistance
  • Vector biology and transmission
  • Systems biology
  • Emerging challenges and new tools

The conference series brings malaria researchers from around the world to present and share recent ground-breaking findings on fundamental malaria research in an integrated and highly collaborative environment.
The virtual BioMalPar will have:

  • live-streamed keynotes and short talks
  • lively Q&A sessions
  • digital poster presentations
  • a dedicated discussion platform for knowledge exchange and networking
  • access to recordings of some of the talks after the conference

What past participants say about the conference:

"This was my first time attending a virtual conference and the organisers did a good job at hosting and trying to resolve technical glitches efficiently. There was more ease in participation and engaging speakers with questions through virtual chats compared to conventional conference events. Through this virtual conference, I was exposed to the leading edge of malaria research which would provide new perspectives, flexibility, and build my expertise to inject value to my research in immunopathogenesis in Malaria." - Samantha Nguee, Singapore Immunology Network (SIgN), A*STAR, Singapore. 


EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme

Founder partners

  • Leica logo
  • Olympus logo

Corporate partners

  • 10x Genomics_120x82
  • Becton Dickinson logo
  • Bio-Rad logo
  • Boehringer Ingelheim logo
  • Eppendorf logo
  • GSK logo
  • Milteniy Biotec logo
  • NetApp logo
  • Stilla logo
  • ThermoFisher logo

Associate partners

  • Merck logo
  • New England Biolabs logo
  • Nikon logo
  • Promega logo
  • Roche logo
  • Sanofi logo
  • Sartorius logo